Breaking RepliCel (OTCQB: $REPCF; TSX: $RP.V) @RepliCel News; US Patent Issued to for its Novel Dermal Injection Technologies

Breaking RepliCel (OTCQB: $REPCF; TSX: $RP.V) @RepliCel News; US Patent Issued to for its Novel Dermal Injection Technologies

With exclusive U.S. rights to RCI-02 patents, RepliCel edges its nearest-term commercial asset closer to launch in large aesthetic market

VANCOUVER, BC – April 25, 2017 - (Investorideas.com Newswire) RepliCel Life Sciences Inc. (OTCQB ... Read more

Tuesday, 2017, April 25 - 21:17

Four Stocks Competing in the Medical Aesthetic Market; (NYSE: $AGN), (OTCQB: $REPCF) (TSXV: $RP), (NASDAQ: $HOLX), (ZLTQ)

Four Stocks Competing in the Medical Aesthetic Market; (NYSE: $AGN), (OTCQB: $REPCF) (TSXV: $RP), (NASDAQ: $HOLX), (ZLTQ)

Point Roberts, WA, -April 25, 2017 – Investorideas.com, a global news source covering biotech and medical technology, issues a sector close–up on publicly traded companies competing in the rapidly growing medical aesthetic market.

Company news from Allergan (NYSE: AGN), ... Read more

Tuesday, 2017, April 25 - 21:23